reports
Vistry Group: 1 director
A director at Vistry Group bought 23,172 shares at 1,181p and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
Zhejiang Narada Power Source Co Ltd: 1 director
A director at Zhejiang Narada Power Source Co Ltd maiden bought 50,000 shares at 10.450CNY and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ov...
- Taras Kotovych
- ABGSC Services Research
- Ali Shemmari
- Petter Nystrøm
Avista Corp. Reports Financial Results for the First Quarter of 2024, ...
Avista Corp. Reports Financial Results for the First Quarter of 2024, Confirms 2024 Earnings Guidance First quarter consolidated earnings per diluted share of $0.91, in line with expectationsConfirms consolidated earnings guidance of $2.36 to $2.56 per diluted share SPOKANE, Wash., May 01, 2024 (GLOBE NEWSWIRE) -- Avista Corp. (NYSE: AVA) today announced financial results for the first quarter of 2024. Net income and earnings per diluted share for the first quarter of 2024 compared to the first quarter of 2023 are presented in the table below (dollars in thousands, except per-share data)...
Hardman & Co Research on City of London Investment Group (CLIG): Posi...
Hardman & Co Research Hardman & Co Research on City of London Investment Group (CLIG): Positive inflows boost FUM 01-May-2024 / 11:58 GMT/BST The issuer is solely responsible for the content of this announcement. Hardman & Co Research on City of London Investment Group (CLIG): Positive inflows boost FUM City of London has announced its FUM for 3Q’24. It was a positive quarter, with group FUM rising 5.5%, from $9.58bn to $10.10bn. The largest contribution came from a positive market backdrop: all the benchmark indices for CLIM strategies delivered positive returns over the...
Olema Oncology to Participate in Upcoming Investor Conferences in May
Olema Oncology to Participate in Upcoming Investor Conferences in May SAN FRANCISCO, May 01, 2024 (GLOBE NEWSWIRE) -- (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers, today announced that its management team will participate in the following upcoming investor conferences: BofA Securities Health Care Conference 2024Date: Tuesday, May 14, 2024, at 4:35 p.m. PTLocation: Encore Hotel in Las Vegas, NVFormat: Presentation H.C. Wainwright 2nd Annual BioC...
Astec Reports First Quarter 2024 Results
Astec Reports First Quarter 2024 Results First Quarter 2024 Overview (all comparisons are made to the corresponding prior year first quarter unless otherwise specified): Implied orders increased 2.4% sequentially from the fourth quarter.Backlog of $559.8 million as of March 31, 2024 approaching historical range.Net sales decreased 11.1% to $309.2 million. Gross margin of 24.9% decreased 70 basis points. Diluted EPS of $0.15 compared to $0.53; Adjusted EPS of $0.34 compared to $0.90. Federal highway and pavement contract awards increased 11% year-over-year.Record attendance at 2024 Wo...
Widmer Brothers Brewing Launches New Hefe Variety Pack With Revamped V...
Widmer Brothers Brewing Launches New Hefe Variety Pack With Revamped Versions of the Original American Hefeweizen New Variety 12-pack Features Hefe, Widberry Hefe, Apricot Hefe and Imperial Hefe PORTLAND, Ore., May 01, 2024 (GLOBE NEWSWIRE) -- (“”), brewers of The Original American Hefeweizen, and a subsidiary of Tilray Brands, Inc. (“Tilray”) (NASDAQ: TLRY and TSX: TLRY), is launching a new Hefe Variety 12 Pack, showcasing a wide range of delicious wheat beer style brews. As creators of the American Wheat Beer style, Widmer Brothers has always been a leader in showcasing how wheat ...
Akoustis Receives Two Design Wins with Tier-1 Network Infrastructure C...
Akoustis Receives Two Design Wins with Tier-1 Network Infrastructure Customer Tier-1 Customer to Use High-Performance Akoustis XBAW® Filters for Two Wi-Fi 7 Fixed Wireless Access Enterprise and Home Gateway PlatformsCompany Has Received Orders to Support Production Ramp Throughout Calendar Year 2024 Charlotte, N.C., May 01, 2024 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today the in...
Dayforce Reports First Quarter 2024 Results
Dayforce Reports First Quarter 2024 Results Dayforce® recurring revenue of $337.2 million, up 24.3%, and excluding float revenue, up 23.0% Total revenue of $431.5 million, up 16.4% Operating profit of $40.7 million and adjusted operating profit of $109.1 million MINNEAPOLIS and TORONTO, May 01, 2024 (GLOBE NEWSWIRE) -- Dayforce, Inc. ("Dayforce" or the "Company") (NYSE:DAY) (TSX:DAY), a global leader in human capital management ("HCM") technology, today announced its financial results for the first quarter ended March 31, 2024. “I am pleased to report another strong quarter for Dayfor...
Lee Enterprises adds Chief Transformation and Commercial Officer
Lee Enterprises adds Chief Transformation and Commercial Officer DAVENPORT, Iowa, May 01, 2024 (GLOBE NEWSWIRE) -- Les Ottolenghi, a Fortune 500 senior technology and cybersecurity executive, has joined Lee Enterprises, Incorporated (NASDAQ:LEE), as Chief Transformation and Commercial Officer. Kevin Mowbray, Lee’s President and Chief Executive Officer, said the senior-level role was created to advance and accelerate Lee’s industry-leading digital growth and further strengthen market supremacy. “Les brings over 25 years of leadership experience in large public corporations an...
Apellis Announces 11 Oral Presentations at the Association for Researc...
Apellis Announces 11 Oral Presentations at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting WALTHAM, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that 14 abstracts, 11 of which are oral presentations, will be presented at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting to be held May 5 - 9 in Seattle. The data continue to reinforce the robust efficacy and safety profile of SYFOVRE® (pegcetacoplan injection) for geographic atrophy (GA) secondary to age-related macular degene...
Berry Corporation Reports First Quarter 2024 Financial and Operating R...
Berry Corporation Reports First Quarter 2024 Financial and Operating Results, Declares Dividend DALLAS, May 01, 2024 (GLOBE NEWSWIRE) -- Berry Corporation (bry) (NASDAQ: BRY) (“Berry” or the “Company”) announced first quarter 2024 results and declared a fixed dividend. The details for today’s earnings call and webcast are listed below. Quarterly Highlights & Recent Announcements Produced 25,400 boe/d, above the midpoint of 2024 annual guidance of 25,200 boe/dDeclared first quarter fixed dividends of $0.12 per shareAcquired all necessary 2024 California G...
Bitfarms Provides April 2024 Production and Operations Update
Bitfarms Provides April 2024 Production and Operations Update - Earns 269 BTC in April 2024 -- Improves corporate energy efficiency 9% to 31 w/TH -- Tracking to 21 EH/s and 21 w/TH in 2024 with transformative fleet upgrade -- Expects VAT refund from Canada of US $23.7M - This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated March 8, 2024, to its short form base shelf prospectus dated November 10, 2023. TORONTO, Ontario and BROSSARD, Québec, May 01, 2024 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ/ TSX: BITF), a global vert...
Springbig Applauds DEA’s Recent Reclassification of Marijuana
Springbig Applauds DEA’s Recent Reclassification of Marijuana DEA's Reclassification of Marijuana Boosts Business Opportunities and Consumer Access, Signaling a New Era for the Cannabis Industry BOCA RATON, Fla., May 01, 2024 (GLOBE NEWSWIRE) -- Springbig, a leading provider of marketing solutions for the cannabis industry, expressed their strong support for the Drug Enforcement Administration's (DEA) decision to reclassify marijuana as a lower-risk drug, announced yesterday. Reflecting the broad societal trends in the last decade-plus, this move from the DEA proves that the federal gov...
Axsome Therapeutics Recognizes May as Mental Health Awareness Month
Axsome Therapeutics Recognizes May as Mental Health Awareness Month NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today is joining the global community of mental health advocates, including Mental Health America, during May’s Mental Health Month to raise awareness of the importance of mental health as a key element of overall health. Axsome is committed to the millions of individuals living with mental health conditions...
BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Re...
BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes SUNNYVALE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the primary endpoint results of the open label roll-in cohort of the CardiAMP® Cell Therapy in Chronic Myocardial Ischemia Trial. Study clinical cardiology leadership and members of the Executive Steering Committee, Dr. Carl Pepine, Professor of Medicine a...
Bombardier fournit des détails sur la commande ferme passée en décembr...
Bombardier fournit des détails sur la commande ferme passée en décembre 2023 par le client NetJets pour 12 avions Challenger 3500 et 232 options NetJets, précieux client de longue date de Bombardier, a été dévoilé comme étant le client qui a passé cette commande ferme en décembre. La commande ferme pour 12 avions d’affaires Challenger 3500 était estimée à 326,4 millions $ US aux prix courants au moment de sa signatureSi toutes les 232 options étaient exercées au fil du temps, la transaction pourrait valoir plus de 6 milliards $ US aux prix courantsCette commande réaffirme les solides liens ...
Bombardier Provides Details of December 2023 Firm Order by Customer Ne...
Bombardier Provides Details of December 2023 Firm Order by Customer NetJets for 12 Challenger 3500 Aircraft and 232 Options Bombardier’s long-time valued client NetJets was unveiled as the customer who placed this order in December. The firm order for the 12 Challenger 3500 jets was valued at US$326.4 million based on list prices at the time of signingIf all 232 Challenger 3500 options are exercised over time, the transaction could be valued at more than US$6 billion based on list pricesThe order reaffirms the strong ties between the companies and underscores the continued supremacy of the ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.